MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

The Senate has voted to confirm the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Publicly traded ...

Radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) more than doubled ...

It will compare the shot against a ... to a current vaccine due to start shortly. Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property ...

For comparison, Pfizer reported yesterday that Abrysvo made ... try to stay ahead of other potential competitors, including Moderna and Bavarian Nordic. Meanwhile, the rivalry between the two ...

Stephanie Lee Griffin; Chief Operating Officer; Roivant Sciences Ltd. Matt Gline; Chief Executive Officer, Director; Roivant Sciences Ltd. Dave Risinger; Analyst; Le ...

Q3 2024 Earnings Call Transcript February 10, 2025 Roivant Sciences Ltd. beats earnings expectations. Reported EPS is $0.23, expectations were $-0.24. Operator: Ladies and gentlemen, thank you for ...

Infected sea urchin on Reunion Island. Photo credit: Jean-Pascal Quod.

There are growing concerns about the worldwide expansion of coral reef destruction. Research team: “This is an extremely ...

“Mistakes that resulted in clinical data that was much more complex to interpret than Moderna’s and Pfizer’s. And on top of that the efficacy is lower.” Technology, price and storage. The AstraZeneca ...

An international team of researchers led by scientists from Tel Aviv University (TAU) has discovered that the pathogen ...